The earliest signs of trial risk may appear before the first patient is ever enrolled. Training completion tells you who finished. It does not necessarily
The formal Formal adoption of the E6(R3) guideline introduces a proportionate and more modern risk-based approach to quality management. Clinical trial leaders must implement more effective training programs that address increased trial complexity and ensure compliance with the enhanced quality requirements.
What learning science has taught us about the drivers and predictors of change—and applying those to clinical research practice. This article was first posted November
Trial sponsors don’t miss timelines because they’re careless. They miss them because they’re human. Behavioral science calls it the planning fallacy.
We talk a lot about processes and platforms in clinical trials. But in the end, success comes down to understanding and supporting the needs of the people conducting the trial.
Four strategies for implementing this approach in clinical trial staff and site training. Brian S. McGowan, PhD, FACEHP, Chief Learning Officer and Co-Founder, ArcheMedX, Inc.
Ready has powered more than 1,000,000 user sessions with clinical professionals from over 90 countries to become the preferred study training tool for over 80% of site personnel.
We all like to believe trial decisions are purely rational. But behavioral science says otherwise. Trial teams rely on mental shortcuts, or heuristics, to make complex decisions faster. These shortcuts can be helpful in the moment, but they also introduce risk.
The concept of sludge provides an invaluable lens for clinical research professionals in identifying and mitigating unnecessary friction and bottlenecks.
Leverage an essential, new set of behaviorally informed best practices to break free from the constraints of the Iron Triangle of Clinical Trial Complexity.
In clinical trials, we often talk about “change” as if it’s a single, uniform challenge. But the reality is very different.
Trial leaders recognize traditional site initiation processes often lead to excessive delays but have struggled to adapt and improve.
Learn the value of slow thinking in enhancing decision-making and outcomes in clinical research and beyond.
ArcheMedX helps life sciences and healthcare organizations to better equip, evaluate, and predict team and clinician performance
